182 related articles for article (PubMed ID: 37871298)
21. Time-Series-Dependent Global Data Filtering Strategy for Mining and Profiling of Xenobiotic Metabolites in a Dynamic Complex Matrix: Application to Biotransformation of Flavonoids in the Extract of
Wang HY; Qu C; Li MN; Li CR; Liu RZ; Guo Z; Li P; Gao W; Yang H
J Agric Food Chem; 2022 Nov; 70(45):14386-14394. PubMed ID: 36331925
[TBL] [Abstract][Full Text] [Related]
22. Human gut microbiota plays a role in the metabolism of drugs.
Jourova L; Anzenbacher P; Anzenbacherova E
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Sep; 160(3):317-26. PubMed ID: 27485182
[TBL] [Abstract][Full Text] [Related]
23. The role of gut microbiota in the pharmacokinetics of antihypertensive drugs.
Choi MS; Yu JS; Yoo HH; Kim DH
Pharmacol Res; 2018 Apr; 130():164-171. PubMed ID: 29391236
[TBL] [Abstract][Full Text] [Related]
24. Gut Microbiome: The Interplay of an "Invisible Organ" with Herbal Medicine and Its Derived Compounds in Chronic Metabolic Disorders.
Lim DW; Wang JH
Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36293657
[TBL] [Abstract][Full Text] [Related]
25. The Gut Microbiome and Xenobiotics: Identifying Knowledge Gaps.
Sutherland VL; McQueen CA; Mendrick D; Gulezian D; Cerniglia C; Foley S; Forry S; Khare S; Liang X; Manautou JE; Tweedie D; Young H; Alekseyenko AV; Burns F; Dietert R; Wilson A; Chen C
Toxicol Sci; 2020 Jul; 176(1):1-10. PubMed ID: 32658296
[TBL] [Abstract][Full Text] [Related]
26. Connecting the dots: Targeting the microbiome in drug toxicity.
Luo Y; Zhou T
Med Res Rev; 2022 Jan; 42(1):83-111. PubMed ID: 33856076
[TBL] [Abstract][Full Text] [Related]
27. Gut microbiome interactions with drug metabolism, efficacy, and toxicity.
Wilson ID; Nicholson JK
Transl Res; 2017 Jan; 179():204-222. PubMed ID: 27591027
[TBL] [Abstract][Full Text] [Related]
28. Microbial Biocatalysis within Us: The Underexplored Xenobiotic Biotransformation Potential of the Urinary Tract Microbiota.
Marti TD; Schärer MR; Robinson SL
Chimia (Aarau); 2023 Jun; 77(6):424-431. PubMed ID: 38047782
[TBL] [Abstract][Full Text] [Related]
29. The role of gut microbiota for the activity of medicinal plants traditionally used in the European Union for gastrointestinal disorders.
Thumann TA; Pferschy-Wenzig EM; Moissl-Eichinger C; Bauer R
J Ethnopharmacol; 2019 Dec; 245():112153. PubMed ID: 31408679
[TBL] [Abstract][Full Text] [Related]
30. GLORYx: Prediction of the Metabolites Resulting from Phase 1 and Phase 2 Biotransformations of Xenobiotics.
de Bruyn Kops C; Šícho M; Mazzolari A; Kirchmair J
Chem Res Toxicol; 2021 Feb; 34(2):286-299. PubMed ID: 32786543
[TBL] [Abstract][Full Text] [Related]
31. Biotransformation of Liquiritigenin into Characteristic Metabolites by the Gut Microbiota.
Keranmu A; Pan LB; Fu J; Han P; Yu H; Zhang ZW; Xu H; Yang XY; Hu JC; Zhang HJ; Bu MM; Jiang JD; Xing NZ; Wang Y
Molecules; 2022 May; 27(10):. PubMed ID: 35630532
[TBL] [Abstract][Full Text] [Related]
32. Gut Microbiome and Response to Cardiovascular Drugs.
Tuteja S; Ferguson JF
Circ Genom Precis Med; 2019 Sep; 12(9):421-429. PubMed ID: 31462078
[TBL] [Abstract][Full Text] [Related]
33. Gut microbiota metabolism and the permeability of natural products contained in infusions from herb of European goldenrod Solidago virgaurea L.
Popowski D; Czerwińska ME; Kruk A; Pawłowska KA; Zentek J; Melzig MF; Piwowarski JP; Granica S
J Ethnopharmacol; 2021 Jun; 273():113924. PubMed ID: 33607199
[TBL] [Abstract][Full Text] [Related]
34. MASI: microbiota-active substance interactions database.
Zeng X; Yang X; Fan J; Tan Y; Ju L; Shen W; Wang Y; Wang X; Chen W; Ju D; Chen YZ
Nucleic Acids Res; 2021 Jan; 49(D1):D776-D782. PubMed ID: 33125077
[TBL] [Abstract][Full Text] [Related]
35. Microbiota-Host Transgenomic Metabolism, Bioactive Molecules from the Inside.
Turroni S; Brigidi P; Cavalli A; Candela M
J Med Chem; 2018 Jan; 61(1):47-61. PubMed ID: 28745893
[TBL] [Abstract][Full Text] [Related]
36. The Gut Microbiota Impact Cancer Etiology through "Phase IV Metabolism" of Xenobiotics and Endobiotics.
Ervin SM; Redinbo MR
Cancer Prev Res (Phila); 2020 Aug; 13(8):635-642. PubMed ID: 32611614
[TBL] [Abstract][Full Text] [Related]
37. Biotransformation of dietary phytoestrogens by gut microbes: A review on bidirectional interaction between phytoestrogen metabolism and gut microbiota.
Seyed Hameed AS; Rawat PS; Meng X; Liu W
Biotechnol Adv; 2020 Nov; 43():107576. PubMed ID: 32531317
[TBL] [Abstract][Full Text] [Related]
38. Physiologically based kinetic (PBK) modeling as a new approach methodology (NAM) for predicting systemic levels of gut microbial metabolites.
Stevanoska M; Folz J; Beekmann K; Aichinger G
Toxicol Lett; 2024 May; 396():94-102. PubMed ID: 38685289
[TBL] [Abstract][Full Text] [Related]
39. Cyanidin-3-O-glucoside impacts fecal discharge of polystyrene microplastics in mice: Potential role of microbiota-derived metabolites.
Chen W; Tu P; Ye X; Tang Q; Yu T; Zheng X
Toxicol Appl Pharmacol; 2022 Oct; 453():116212. PubMed ID: 36057402
[TBL] [Abstract][Full Text] [Related]
40. Application of artificial intelligence approaches to predict the metabolism of xenobiotic molecules by human gut microbiome.
Malwe AS; Sharma VK
Front Microbiol; 2023; 14():1254073. PubMed ID: 38116528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
